Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Health Care

57.95
+1.522.69%
Post-market: 57.950.00000.00%16:10 EDT
Volume:14.96K
Turnover:867.49K
Market Cap:96.78M
PE:- -
High:58.42
Open:57.85
Low:57.59
Close:56.43
52wk High:64.60
52wk Low:39.32
Shares:1.67M
Float Shares:1.67M
Volume Ratio:2.04
T/O Rate:0.90%
Dividend:0.71
Dividend Rate:1.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc

THOMSON REUTERS
·
Yesterday

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS
·
Yesterday

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS
·
Yesterday

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Yesterday

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Yesterday

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Reuters
·
Yesterday

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Yesterday

Johnson & Johnson reports PAPILLON study meets primary endpoint

TIPRANKS
·
Yesterday

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Yesterday

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Yesterday

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Yesterday

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Yesterday

J&J Shares up 1.2% Premarket After Report Co's Orthopedics Unit Draws Apollo Interest in Potential $20 Bln Deal

THOMSON REUTERS
·
Yesterday

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Yesterday

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Yesterday

J&J - Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Nsclc

THOMSON REUTERS
·
Yesterday

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Yesterday

Rox Resources Extends High-Grade Youanmi Ore Ahead of Production

TIPRANKS
·
Yesterday

Johnson & Johnson in Advanced Talks to Sell Orthopaedics Unit to Apollo in Potential $20B Deal

Deep News
·
Sep 13

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12